Model structure and control of bone remodeling: a theoretical study.
It is generally accepted that RANKL is highly expressed in osteoblast precursor cells while OPG is highly expressed in mature osteoblasts, but to date no functional utility to the BMU has been proposed for this particular ligand-decoy-receptor expression profile. As discovered in the mid 90s, the RANK-RANKL-OPG signaling cascade is a major signaling pathway regulating bone remodeling. In this paper we study theoretically the functional implications of particular RANKL/OPG expression profiles on bone volume. For this purpose we formulate an extended bone-cell dynamics model describing functional behaviour of basic multicellular units (BMUs) responsible for bone resorption and formation. This model incorporates the RANK-RANKL-OPG signaling together with the regulating action of TGF-beta on bone cells. The bone-cell population model employed here builds on the work of Lemaire et al. (2004) [1], but incorporates the following significant modifications: (i) addition of a rate equation describing changes in bone volume with time as the key 'output function' tracking functional behaviour of BMUs, (ii) a rate equation describing release of TGF-beta from the bone matrix, (iii) expression of OPG and RANKL on both osteoblastic cell lines, and (iv) modified activator/repressor functions. Using bone volume as a functional selection criterion, we find that there is a preferred arrangement for ligand expression on particular cell types, and further, that this arrangement coincides with biological observations. We then investigate the model parameter space combinatorially, searching for preferred 'groupings' of changes in differentiation rates of various cell types. Again, a criterion of bone volume change is employed to identify possible ways of optimally controlling BMU responses. While some combinations of changes in differentiation rates are clearly unrealistic, other combinations of changes in differentiation rates are potentially functionally significant. Most importantly, the combination of parameter changes representing the signaling pathway for TGF-beta gives a unique result that appears to have a clear biological rationale. The methodological approach for the investigation of model structure described here offers a theoretical explanation as to why TGF-beta has its particular suite of biological effects on bone-cell differentiation rates.
Pivonka
Peter
P
Department of Civil and Environmental Engineering, University of Melbourne, VIC 3010, Australia.
Zimak
Jan
J
Department of Civil and Environmental Engineering, University of Melbourne, VIC 3010, Australia.
Smith
David W
DW
Department of Civil and Environmental Engineering, University of Melbourne, VIC 3010, Australia. Electronic address: david.smith@unimelb.edu.au.
Gardiner
Bruce S
BS
Department of Civil and Environmental Engineering, University of Melbourne, VIC 3010, Australia.
Dunstan
Colin R
CR
Bone Biology Unit, ANZAC Research Institute, Concord, NSW 2139, Australia.
Sims
Natalie A
NA
Department of Medicine at St. Vincent's Hospital, University of Melbourne, VIC, 3065, Australia.
John Martin
T
T
Department of Medicine at St. Vincent's Hospital, University of Melbourne, VIC, 3065, Australia.
Mundy
Gregory R
GR
Center for Bone Biology, Vanderbilt University, Nashville, 37232-0575, USA.
D000818:Animals; D017209:Apoptosis; D016723:Bone Remodeling; D006801:Humans; D008954:Models, Biological; D009929:Organ Size; D010006:Osteoblasts / Q000166:cytology; D053244:Osteoprotegerin / Q000378:metabolism; D053245:RANK Ligand / Q000378:metabolism
D053244:Osteoprotegerin; D053245:RANK Ligand